Literature DB >> 6273502

Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.

O M Kew, B K Nottay, M H Hatch, J H Nakano, J F Obijeski.   

Abstract

Poliovirus isolates of serotypes 2 and 3 from patients whose paralytic poliomyelitis cases were classified as oral vaccine-associated were analysed by oligonucleotide mapping of the virus genomes and by polyacrylamide gel electrophoresis of the virus proteins. Oligonucleotide maps of all isolates were similar to the maps of the corresponding oral vaccine strain. No two isolates gave identical maps. Most maps differed from that of the vaccine strain by at least one oligonucleotide spot. Maps of some isolates revealed numerous differences, indicating that multiple (greater than 100) genetic changes had occurred in the vaccine virus genomes during replication in one or two individuals. In contrast, maps of some neural tissue isolates showed minimal differences from the reference vaccine maps, raising the possibility that neurovirulence may be restored by a small number of genetic changes. For many isolates, changes were also detected in the mobilities of processing rates of the virus proteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273502     DOI: 10.1099/0022-1317-56-2-337

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  46 in total

1.  Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.

Authors:  G V Gavrilin; E A Cherkasova; G Y Lipskaya; O M Kew; V I Agol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.

Authors:  J M Tatem; C Weeks-Levy; A Georgiu; S J DiMichele; E J Gorgacz; V R Racaniello; F R Cano; S J Mento
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Impact on routine diagnosis of echovirus infections of intratypic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodies.

Authors:  H Peigue-Lafeuille; F Fuchs; F Gharabaghi; M Chambon; M Aymard
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

4.  Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses.

Authors:  J J Holland; J C de la Torre; D K Clarke; E Duarte
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde.

Authors:  M Chambon; C Jallat-Archimbaud; J L Bailly; J M Gourgand; F Charbonne; C Henquell; F Fuchs; H Peigue-Lafeuille
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

6.  Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.

Authors:  E Bellelli; M L Tanzi; V Bocelli; U Bracchi; P Affanni
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

7.  Identification of vaccine-related polioviruses by hybridization with specific RNA probes.

Authors:  L De; B Nottay; C F Yang; B P Holloway; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

8.  Characterization of genetic changes occurring in attenuated poliovirus 2 during persistent infection in mouse central nervous systems.

Authors:  E J Rozhon; A K Wilson; B Jubelt
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.

Authors:  G Stanway; P J Hughes; R C Mountford; P Reeve; P D Minor; G C Schild; J W Almond
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Genetic and phenotypic characteristics of enterovirus 71 isolates from patients with encephalitis and with hand, foot and mouth disease.

Authors:  A Hagiwara; T Yoneyama; S Takami; I Hashimoto
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.